In an era of increasingly individualized healthcare, Elizabeth Philp has become a significant force of innovation, especially in the technologically advancing field of compounded pharmacy. As the chief executive and co-founder of Roseway Labs, Philp is at the vanguard of a movement to make custom medications more available, questioning the convent